The authors discuss pertinent studies concerning Tregs in hepatitis B virus (HBV) infection, HBV-related cirrhosis, and HCC. Furthermore, they summarize Treg responses to antiviral therapy and provide Treg-targeted therapies specific to HBV and HCC.
[Immunology]